Table 4.
Outcomes of KTx on a vascular bypass.
| Study | N | DGF (%) | EC (%) | Re‐operation (%) | Patient survival (%) | Graft survival DC (%) | Uncensored graft survival (%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 days | 1 year | 3 years | 5 years | 30 days | 1 year | 3 years | 5 years | 30 days | 1 year | 3 years | 5 years | ||||||
|
Ozcelik Germany |
2007 | 11 | 2/11 (18.2) | 3/11 (27.3) | 1/11 (9.1) | NA | NA | NA | NA | 8/11 (72.7) | NA | NA | NA | 8/11 (72.7) | NA | NA | NA |
|
Patrono Belgium |
2013 | 27 | 2/27 (7.4) | 5/27 (7.4) | 1/27 (3.7) | NA | 24/27 (88.9) | 23/27 (85.2) | 23/27 (85.2) | NA | 26/27 (96.3) | 26/27 (96.3) | 24/27 (88.9) | NA | 24/27 (88.9) | 22/27 (81.5) | 20/27 (74.1) |
|
Tozzi, Italy |
2013 | 4 | 0/4 (0) | 0/4 (0) | 0/4 (0) | 4/4 (100) | 4/4 (100) | NA | NA | 4/4 (100) | 4/4 (100) | NA | NA | 4/4 (100) | 4/4 (100) | NA | NA |
|
Sagban German |
2016 | 4 | NA | 1/4 (25) | 1/4 (25) | 4/4 (100) | 4/4 (100) | NA | NA | 4/4 (100) | 4/4 (100) | 4/4 (100) | 4/4 (100) | 4/4 (100) | 4/4 (100) | NA | NA |
|
Franquet France |
2018 | 11 | 0/11 (0) | 2/11 (27.3) | 1/11 (9.1) | 11/11 (100) | 11/11 (100) | 9/11 (81.8) | NA | 11/11 (100) | 9/11 (81.8) | NA | NA | 11/11 (100) | 9/11 (81.8) | NA | NA |
| Total | 57 | 4/53 (7.5) | 11/57 (19.3) | 4/57 (7.0) | 19/19 (100) | 43/46 (93.5) | 32/38 (84.2) | 23/27 (85.2) | 27/30 (90.0) | 43/46 (93.5) | 30/31 (96.8) | 28/31 (90.3) | 27/30 (90.0) | 41/46 (89.1) | 22/27 (81.5) | 20/27 (74.1) | |
DC, death‐censored; DGF, delayed graft function; EC, early complications; NA, not applicable.